Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices

See what CB Insights has to offer


Dead | Dead

Total Raised


About LumeRx

LumeRx is a medical device company developing novel light-based therapies for the treatment of diseases caused by bacterial and other pathogenic infections. Its first device will deliver a specific wavelength of light to the stomach to eradicate h. pylori, the bacteria causing peptic ulcer disease (PUD) and believed to be the cause of gastric cancer.

LumeRx Headquarter Location

100 Locke Drive

Marlborough, Massachusetts, 01752,

United States


Latest LumeRx News

DeadMed: R.I.P

Aug 7, 2017

May, 2008 - LumeRx reported several events concerning its plans moving forward. Trial results analysis from work recently completed in India reveals current visible light approaches are not adequate as a primary treatment for H. Pylori. As a result of these findings, the Company's investors have decided to not invest further in LumeRx and to scale back operations. Jon McGrath has stepped down from his position as CEO with day-to-day responsibilities assumed by David Hendren of Catalyst Health Ventures. Catalyst and other investors are now considering the future course for the LumeRx.,-Gabrieli-ends-funding.html Posted by

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LumeRx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LumeRx is included in 2 Expert Collections, including Smart Money VCs (2017-2019).


Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.